802
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Transdermal alcohol monitoring combined with contingency management for driving while impaired offenders: A pilot randomized controlled study

, , , , , & show all
Pages 455-461 | Received 20 Apr 2017, Accepted 28 Feb 2018, Published online: 11 May 2018

References

  • Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;330:843.
  • Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. Geneva, Switzerland: World Health Organization; 2001.
  • Barnett NP, Souza T, Rosen IG, Luczak SE, Glynn TR, Swift R. Transdermal Alcohol Sensor Data Macro Version 1.1 [computer program]. Providence, RI: Brown University; 2015.
  • Barnett NP, Tidey J, Murphy JG, Swift R, Colby SM. Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor. Drug Alcohol Depend. 2011;118:391–399.
  • Benishek LA, Dugosh KL, Kirby KC, et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109:1426–1436.
  • Brown SW, Vanlaar W, Robertson R. Alcohol and Drug-Crash Problem in Canada 2012 Report. Ottawa, ON: Traffic Injury Research Foundation; 2015.
  • Brown TG, Dongier M, Ouimet MC, et al. Brief motivational interviewing for DWI recidivists who abuse alcohol and are not participating in DWI intervention: a randomized controlled trial. Alcohol Clin Exp Res. 2010;34:292–301.
  • Brown TG, Ouimet MC. Treatments for alcohol-related impaired driving. In: McMurran M, ed. Alcohol-Related Violence: Prevention and Treatment. Chichester, UK: Wiley-Blackwell; 2013:303–334.
  • Brown TG, Ouimet MC, Nadeau L, et al. DUI offenders who delay relicensing: a quantitative and qualitative investigation. Traffic Inj Prev. 2008;9(2):109–118.
  • Dawson DA, Grant BF, Li TK. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res. 2005;29:902–908.
  • DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23:207–218.
  • Dougherty DM, Charles NE, Acheson A, John S, Furr RM, Hill-Kapturczak N. Comparing the detection of transdermal and breath alcohol concentrations during periods of alcohol consumption ranging from moderate drinking to binge drinking. Exp Clin Psychopharmacol. 2012;20(5):373–381.
  • Dougherty DM, Hill-Kapturczak N, Liang Y, et al. Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use. Drug Alcohol Depend. 2014;142:301–306.
  • Dougherty DM, Karns TE, Mullen J, et al. Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking. Drug Alcohol Depend. 2015;148:77–84.
  • Elder RW, Voas R, Beirness D, et al. Effectiveness of ignition interlocks for preventing alcohol-impaired driving and alcohol-related crashes: a community guide systematic review. Am J Prev Med. 2011;40:362–376.
  • Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract. 1990;40(332):114–116.
  • Hagenzieker MP, Bijleveld FD, Davidse RJ. Effects of incentive programs to stimulate safety belt use: a meta-analysis. Accid Anal Prev. 1997;29:759–777.
  • Hingson R, Winter M. Epidemiology and consequences of drinking and driving. Alcohol Res Health. 2003;27:63–78.
  • Hoeppner BB, Stout RL, Jackson KM, Barnett NP. How good is fine-grained Timeline Follow-back data? Comparing 30-day TLFB and repeated 7-day TLFB alcohol consumption reports on the person and daily level. Addict Behav. 2010;35:1138–1143.
  • Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192–203.
  • Marowitz LA. Predicting DUI recidivism: blood alcohol concentration and driver record factors. Accid Anal Prev. 1998;30:545–554.
  • Marques PR, McKnight AS. Field and laboratory alcohol detection with 2 types of transdermal devices. Alcohol Clin Exp Res. 2009;33:703–711.
  • Miller PG, Curtis A, Sonderlund A, Day A, Droste N. Effectiveness of interventions for convicted DUI offenders in reducing recidivism: a systematic review of the peer-reviewed scientific literature. Am J Drug Alcohol Abuse. 2015;41:16–29.
  • NHTSA. Traffic Safety Facts: Alcohol-Impaired Driving. Washington, DC: NHTSA's National Center for Statistics and Analysis; 2016.
  • Ouimet MC, Averill F, Brown TG. L'efficacité de l'entretien motivationnel dans la prévention secondaire et tertiaire de la conduite avec les capacités affaiblies par l'alcool: une revue systématique de la documentation [The effectiveness of Motivational Interviewing in secondary and tertiary prevention of alcohol-impaired driving: A systematic review of the documentation]. Drogues, santé et société. 2014;13(2):84–108.
  • Ouimet MC, Dongier M, Di Leo I, et al. L'efficacité de l'entretien motivationnel dans la prévention secondaire et tertiaire de la conduite avec les capacités affaiblies par l'alcool: une revue systématique de la documentation [A randomized controlled trial of brief Motivational Interviewing in impaired driving recidivists: a 5-year follow-up on traffic offenses and crashes]. Alcohol Clin Exp Res. 2013;37:1979–1985.
  • Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol. 2000;68:250–257.
  • Rauch WJ, Zador PL, Ahlin EM, Howard JM, Frissell KC, Duncan GD. Risk of alcohol-impaired driving recidivism among first offenders and multiple offenders. Am J Public Health. 2010;100:919–924.
  • Rollnick S, Heather N, Gold R, Hall W. Development of a short “readiness to change” questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addict. 1992;87:743–754.
  • Saghaei M. An overview of randomization and minimization programs for randomized clinical trials. J Med Signals Sens. 2011;1:55–61.
  • Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. A review. Control Clin Trials. 2002;23:662–674.
  • Sergl HG, Klages U, Zentner A. Pain and discomfort during orthodontic treatment: causative factors and effects on compliance. Am J Orthod Dentofacial Orthop. 1998;114:684–691.
  • Simpson HM, Beirness DJ, Robertson RD, Mayhew DR, Hedlund JH. Hard core drinking drivers. Traffic Inj Prev. 2004;5(3):261–269.
  • Sobell LC, Brown J, Leo GI, Sobell MB. The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend. 1996;42:49–54.
  • Sobell LC, Sobell MB. Timeline Follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992:41–72.
  • Sobell LC, Sobell MB, Connors GJ, Agrawal S. Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success. Alcohol Clin Exp Res. 2003;27:1661–1666.
  • Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353–1357.
  • Taylor B, Rehm J. The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels. Alcohol Clin Exp Res. 2012;36:1827–1834.
  • Tisson J, Nichols JL, Casanova-Powell T, Chaudhary NK. Comparative Study and Evaluation of SCRAM Use, Recidivism Rates, and Characteristics. Washington, DC: NHTSA; 2015. DOT HS 812 143.
  • Voas RB, Tippetts AS, McKnight AS. DUI offenders delay license reinstatement: a problem? Alcohol Clin Exp Res. 2010;34:1282–1290.
  • Worden BL, Epstein EE, McCrady BS. Pretreatment assessment-related reductions in drinking among women with alcohol use disorders. Subst Use Misuse. 2015;50:215–225.
  • World Health Organization. Global Status Report on Road Safety 2015. Geneva, Switzerland: WHO Press; 2015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.